Welcome to our dedicated page for Trulieve Cannabis news (Ticker: TCNNF), a resource for investors and traders seeking the latest updates and insights on Trulieve Cannabis stock.
Trulieve Cannabis Corp. (TCNNF) generates frequent news across operations, finance, regulation, and product development, reflecting its role as a vertically integrated, multi-state cannabis operator. As an industry leading company with leading market positions in Arizona, Florida, and Pennsylvania, Trulieve’s announcements often cover expansion of its retail footprint, capital markets activity, and responses to evolving cannabis policy in the United States.
Investors and observers following Trulieve news will see regular updates on financial performance, such as quarterly results detailing revenue, gross margin, cash flow, and non-GAAP metrics like adjusted EBITDA and free cash flow. The company also issues press releases about conference calls and investor presentations, providing context on its operating strategy, retail network, and production capacity.
Trulieve’s news flow includes financing developments, such as private placements of senior secured notes, redemptions of existing debt, and related SEC filings. These items outline interest rates, maturities, security pledges, and intended use of proceeds for capital expenditures and general corporate purposes. Such updates are important for understanding the company’s capital structure and liquidity.
Operational news highlights new dispensary openings, licensing agreements, and market entries. For example, Trulieve has announced Trulieve-branded dispensaries in Ohio operated by a partner under license, as well as conditional approval for a Dispensing Organization license under the Texas Compassionate Use Program. Product-focused releases showcase new offerings, including additional flavors of Onward and Upward THC-infused beverages and other branded cannabis products.
Policy and regulatory developments also feature in Trulieve’s news, including its public support for marijuana rescheduling to Schedule III under the Controlled Substances Act. For users tracking TCNNF, this news page offers a centralized view of the company’s financial updates, expansion moves, product launches, and regulatory commentary over time.
Trulieve Cannabis Corp. (OTCQX: TCNNF) announced its participation in two upcoming conferences in March 2022. President Steve White will attend the 34th Annual Roth Conference on March 14, while CMO Valda Coryat will join a panel discussion at the 2022 SXSW Conference on March 15, focusing on cannabis in consumer packaged goods. As a leading multi-state operator in the U.S., Trulieve operates in 11 states, with significant market presence in Arizona, Florida, and Pennsylvania, positioning itself for growth and expansion.
Summary not available.
Trulieve Cannabis Corp. has announced an exclusive partnership with Wiz Khalifa's Khalifa Kush brand, set to launch in Florida this summer. Trulieve will be the exclusive producer, processor, and retailer of Khalifa Kush products in Florida and other northeastern markets. Trulieve is renowned for its extensive range of premium cannabis products, serving the largest medical cannabis market in the U.S. The collaboration aims to enhance customer experiences and expand the brand's footprint across multiple states.
Trulieve Cannabis Corp. is hosting a Listening and Education Tour in Georgia to engage local leaders on the benefits of the cannabis industry. The inaugural event will occur on February 25, 2022, at the Carolyn Harris Performing Arts Center in Adel. Moderated by Champ Bailey, the tour aims to discuss medical, economic, agricultural, and expungement opportunities. Trulieve received a Class 1 production license from the Georgia Access to Medical Cannabis Commission in July 2021. Community participation is encouraged, and future dates will be announced.
Trulieve Cannabis Corp. has finalized the acquisition of a 64,000 sq. ft. cultivation facility in Phoenix, Arizona for $13.75 million. This facility enhances the company’s cultivation capacity and strengthens its market presence in the Southwest. It also serves Trulieve’s 17 dispensaries in Arizona, providing high-quality products to both medical and adult-use customers. CEO Kim Rivers emphasized the strategic importance of this acquisition for improving supply chain capacity and expanding service to a larger customer base.
Trulieve Cannabis Corp. has opened its 112th dispensary in Riverview, Florida, effective February 10, 2022. The new location aims to enhance patient accessibility to medical cannabis and will feature grand opening specials, including a 25% discount for registered patients. Customers also benefit from a 50% discount for first-time visitors at any Florida location. Trulieve emphasizes personalized patient care and offers a variety of THC and CBD products, ensuring comprehensive support throughout the cannabis journey.
Trulieve Cannabis Corp. has announced the launch of two proprietary brands, Sweet Talk™ and Momenta™, alongside new product releases in Florida. The Momenta line focuses on holistic wellness, while Sweet Talk offers tasty edibles, starting with strawberry gels. The company will also release the second batch of Live Diamonds by Muse and introduce the Cultivar Collection of premium whole flower. These offerings aim to enhance Trulieve’s position as a leading cannabis provider in Florida, catering to the growing patient community.
Summary not available.
Trulieve Cannabis Corp. has successfully closed a second tranche of its private placement of 8% Senior Secured Notes, raising US$75.0 million. This follows an earlier tranche in October 2021, bringing total gross proceeds to US$425.0 million. The funds will be allocated for capital expenditures and general corporate purposes. CEO Kim Rivers highlighted the company's strong financial profile, enabling access to favorable growth capital. The Notes will be listed on the Canadian Securities Exchange post a statutory hold period.
Trulieve Cannabis Corp. has partnered with Miami Mango to launch the Mango Haze strain exclusively for South Florida medical patients. Set to debut in late February, this partnership aims to enhance Trulieve's product offerings, showcasing a commitment to quality and patient care. Trulieve continues to dominate Florida's medical cannabis market, providing a wide range of products, including flower, pre-rolls, oils, and concentrates. The company operates in 11 states, emphasizing growth through its hub strategy and a broad selection of THC and CBD products.